Patient Education Sheet Library
Search Results
Trastuzumab, Carboplatin, and Paclitaxel
The combination of trastuzumab, carboplatin, and paclitaxel is used for breast cancer and a type…
Treatment Given by Infusion Treatment Given by InjectionDownloads:
Download (English)Pembrolizumab, Bevacizumab, Cisplatin, and Paclitaxel
The combination of pembrolizumab, bevacizumab, cisplatin, and paclitaxel is used for cervical cancer.
Treatment Given by Infusion Treatment Given by InjectionDownloads:
Pembrolizumab and Cisplatin
The combination of pembrolizumab and cisplatin is used for cervical cancer and head and neck…
Treatment Given by Infusion Treatment Given by InjectionDownloads:
Talquetamab, Pomalidomide and Daratumumab/Hyaluronidase
The combination of talquetamab, pomalidomide, and daratumumab/hyaluronidase is used for multiple myeloma (MM)
Treatment Given by InjectionDownloads:
Talquetamab and Daratumumab/Hyaluronidase
The combination of talquetamab and daratumumab/hyaluronidase is used for multiple myeloma (MM).
Treatment Given by InjectionDownloads:
Palbociclib and Trastuzumab
The combination of palbociclib and trastuzumab is used for breast cancer.
Treatment Given by Infusion Treatment Given by Injection Treatment Taken by MouthDownloads:
Palbociclib, Trastuzumab, and Pertuzumab
The combination of palbociclib, trastuzumab, and pertuzumab is used for breast cancer.
Treatment Given by Infusion Treatment Given by Injection Treatment Taken by MouthDownloads:
Tafasitamab, Rituximab, and Lenalidomide
The combination of tafasitamab, rituximab, and lenalidomide (Tafa-R2) is used for follicular lymphoma (FL).
Treatment Given by Infusion Treatment Given by Injection Treatment Taken by MouthDownloads:
Downloads:
Caplacizumab
Caplacizumab is used for a rare blood disorder called acquired thrombotic thrombocytopenic purpura (aTTP).
Treatment Given by Infusion Treatment Given by InjectionDownloads:
Popular Searches
PES Review Committee
The Patient Education Sheet (PES) Committee is a multidisciplinary team of oncology professionals who guide the development and review of these important resources. This committee ensures that every PES is accurate, clear, and meaningful for patients and caregivers navigating cancer treatment.
Led by NCODA and supported through collaboration with three leading professional organizations—ACCC, HOPA, and ONS—the committee combines expertise from across the oncology care spectrum. Together, they uphold best practices, promote consistency in patient education, and remain committed to improving outcomes through accessible, patient-centered information.
